Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / TripleMed B.V.

Clinicaltrial registered10 Nov 2026

TripleMed B.V.

10 Nov 2026: Trial registered · Safety and Effectiveness Assessment of AneuFix Injectable Polymer Sac Filling to Assure Long-term Durability of EVAR.. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
10 Nov 2026
Title
Safety and Effectiveness Assessment of AneuFix Injectable Polymer Sac Filling to Assure Long-term Durability of EVAR.
Conditions
Endoleak After Endovascular Aneurysm Repair, Aortic Aneurysm Abdominal
Phase
Not applicable
Study Type
Interventional
Status
Not Yet Recruiting
Countries
Netherlands
Country
Netherlands
Reference
NCT07928505
Location
Netherlands
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at TripleMed B.V.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from Netherlands

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.